Evaluation of a Digital Diabetes Self-Management Education and Support Program
Randomized Controlled Trial to Evaluate the Efficacy of an Integrated Lifestyle Management Solution With Continuous Glucose Monitoring for Type 2 Diabetes
Sponsor: Abbott Diabetes Care
Listed as NCT05368454, this NA trial focuses on Type 2 Diabetes and remains completed. Sponsored by Abbott Diabetes Care, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2024 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2023 — May 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2022 — Sep 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Jun 2022 — Jul 2022 [monthly]
Not Yet Recruiting NA
First recorded
May 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Diabetes Care
- Evidation Health
- Omada Health, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .